Shi-Yi Wang

23PUBLICATIONS
56CO-AUTHORS
Gene and molecular therapyAllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Sep 01, 2026
Real-World Efficacy and Safety of Standard-of-Care Chimeric Antigen Receptor T-Cell (CART) and Bispecific T-Cell Engager (TCE) Therapies in Relapsed/Refractory Multiple Myeloma (RRMM).

|Jun 29, 2026
Incidence of depression in patients with psoriasis and psoriatic arthritis treated with biologic therapy: Protocol for a systematic review and meta-analysis.

|May 04, 2026
Immunomodulatory Agent Adherence Trajectories and Survival Among Older Patients With Multiple Myeloma.

|Mar 11, 2026
Quantifying the contribution of modifiable risk factors for progression of MGUS to multiple myeloma in a Veteran population.

Mei Wang, Byron Sigel, Lawrence Liu

|Feb 03, 2026
Adoption and Regional Variation of Prostate-Specific Membrane Antigen Positron Emission Tomography in the United States.

Michael S Leapman, Jessica B Long, Sarah Westvold

|May 12, 2025
High-Deductible Health Plans and Out-of-Pocket Health Care Costs Among Younger Patients With Multiple Myeloma.

Mark Aaron Fiala, Mengmeng Ji, Michael Slade

Pageof 4

Frequent Collaborators

7 joint publications

Sylvia H Hsu

4 joint publications

Mengmeng Ji

4 joint publications

Rong Wang

4 joint publications

Graham A Colditz